Lurbinectedin 4 MG Injection [Zepzelca]
HRI-Lurbinectedin-001
Phase 2 small_molecule completed
Quick answer
Lurbinectedin 4 MG Injection [Zepzelca] for Gastrointestinal Malignancies is a Phase 2 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Gastrointestinal Malignancies
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed